Mutations in the BRCA1 gene are a marker for predicting susceptibility to high-risk cancers, particularly hereditary breast and ovarian cancer syndrome (HBOC), fallopian tube, prostate, and colon cancers. This evidence concerns the gene BRCA1 and Hereditary breast and ovarian cancer syndrome.